MENU
TOVX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Theriva Biologics (TOVX) Ownership - Who owns Theriva Biologics?
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs... Show more
Profile
Industry
N/A
Address
9605 Medical Center Drive
Phone
+1 301 417-4364
Employees
22
Web
https://www.therivabio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.95M
P/E Ratio
N/A
Total Cash
11.61M
Projected Growth
N/A
Total Debt
1.57M
Revenue
N/A
Risk (Beta)
1.13
Dividend Yield
N/A
Total Cash/Share
4.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TOVX
Capitalization
3.95M
P/E Ratio
N/A
Risk (Beta)
1.13
Dividend Yield
N/A
Total Cash
11.6M
Total Cash/Share
4.17
Total Debt
1.57M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
19.1M
P/B Ratio
0.21
Cash Flow
N/A
Earnings
-19.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
2.15
Current Revenue Per Employee
19561.40
Dividends Per Share - Security
N/A
EBITDA
-19.29M
Float
N/A
Float - Current
N/A
Gross Income Margin
11.09
Revenue To Assets
-56.65
Shares Held By Institutions
75.6K
Shares Outstanding - Current
2.78M
Total Liabilities
16.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-18.806
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
9605 Medical Center Drive
Phone
+1 301 417-4364
Employees
22
Web
https://www.therivabio.com